A 5,800 SF state-of-the-art Advanced Therapy Medicinal Product (ATMP) facility featuring six Grade B processing suites with Grade A biosafety cabinets, a dedicated media preparation area, and multiple incubators. The facility also includes locker and gowning areas, supporting clean spaces, a cold room, and all-new MEP generation and distribution systems.
Located in North Carolina, this facility will significantly enhance our client’s manufacturing capabilities and support their mission to develop and manufacture a groundbreaking autologous cell therapy for chronic kidney disease. We are proud to have partnered on a project that advances both innovative biomanufacturing and the future of patient care.
